A Comprehensive Epithelial Tubo- Ovarian Cancer Risk
medRxiv preprint doi: https://doi.org/10.1101/2020.12.04.20244046; this version posted April 13, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . A Comprehensive Epithelial Tubo- Ovarian Cancer Risk Prediction Model Incorporating Genetic and Epidemiological Risk Factors Andrew Lee*1, Xin Yang*1, Jonathan Tyrer2, Aleksandra Gentry-Maharaj3, Andy Ryan3, Nasim Mavaddat1, Alex P. Cunningham1, Tim Carver1, Stephanie Archer4, Goska Leslie1, Jatinderpal Kalsi5,6, Faiza Gaba7, Ranjit Manchanda7,8, Simon A. Gayther9, Susan J. Ramus10,11, Fiona M. Walter4, Marc Tischkowitz12, Ian Jacobs5,10, Usha Menon3, Douglas F. Easton1,2, Paul P.D. Pharoah1,2, Antonis C. Antoniou†1 1 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, The University of Cambridge, Strangeways Research Laboratory, Cambridge CB1 8RN, UK. 2 Centre for Cancer Genetic Epidemiology, Department of Oncology, The University of Cambridge, Cambridge CB1 8RN, UK. 3 MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, London, WC1V 6LJ, UK. 4 The Primary Care Unit, Department of Public Health & Primary Care, The University of Cambridge, Cambridge, CB1 8RN, UK. NOTE:1 This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.04.20244046; this version posted April 13, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.
[Show full text]